Dallas Humble Pleads Guilty to Conspiracy and Distribution of Chinese HGH
Yellow Pages
Written by TAC Staff: Yellow Pages   
Thursday, 30 August 2012 02:41 Read : 733 times

aroundtheworld
MONROE, LA. -- Dallas Humble, a chiropractor, and former practice manager plead guilty to conspiracy against the federal government and illegal distribution of the human growth hormone in the Federal Court building located in Schreveport, Louisiana, Wednesday, July 25th .  The plea deal included admitting guilt to 2 of 22 counts of federal law violations. "According to all the evidence that we saw, he was involved in ordering and also paying for the prescription managing." said Bob Noel, attorney for Dallas Humble.
 
The plea deal put an end to a week-long trial looking into Humble's role in illegal human growth hormone (HGH) purchases from China, along with two others, Doctor Linda Bunch and businessman Paul Temple, who both entered plea deals in 2010. The federal government says a clinic owned by Humble gave patients the drug for anti-aging reasons and other unapproved purposes.  The patients were never told the drugs were illegally imported from China. Noel insists only Dr. Bunch administered the drugs. "Mr. Humble has always held himself as a solid citizen, someone who conducts himself in an honorable fashion, and he is accepting responsibility for his actions. We're going to go forward from here." said Noel.
 
Now Humble must forfeit his property on Cypress Street to the government and along with Dr. Bunch he must also give back the money he earned from HGH sales, which totals over $500,000.00. Humble will be sentenced on December 6 of this year, he face up to 10 years in jail and hundreds of thousands of fines for charge 1 and 5.
 
Source: KNOE 8 News
 

 
User Rating: / 0
PoorBest 
 
TAC Cover
TCA Cover

Click on image above
to view the
Digital Edition


Advertisement

Advertisement

Advertisement

requestmagazinebutton

 

TAC Publications

The American Chiropractor Magazine: Digital Issues | Past Issues | Buyer's Guide

 

More Information

TAC Editorial: About | Circulation | Contact

Sales: Advertising | Subscriptions | Media Kit